class=

Company Name Nikon CeLL innovation Co. Ltd.
Shareholder Nikon Corporation (100%)
Establishment May 7th, 2015
Head Office Shinagawa Intercity Tower C, 2-15-3, Kounan Minato-Ku, Tokyo 108-6290 Japan
Facility Tokyo Grand Port AKB, 2-4-10 Shinsuna, Koto-Ku, Tokyo 136-0075 Japan
CDMO Service Offering
  • Cell and Gene Therapy Process Development (CDO)
  • Cell and Gene Therapy Manufacturing Service (CMO)
Features

Exclusive Collaboration with Lonza to further development of Cell and Gene Therapy manufacturing in Japan

One of the Largest CDMO facility in Japan (6000 m²)

Process Development
  • Technology Transfer
  • Process Development/Optimization
  • Assay Development/Optimization
  • Process Scale-up
GCTP / GMP Manufacturing Service
  • Master Cell Bank Production, Cell Expansion
  • Various Gene Modification Techniques
  • Quality Control
  • Future Expansion Space
  • Supply Chain (storage, shipping, and logistics)
  • Regulatory Support